Benjamin F. Edwards & Company, Inc. Invitae Corp Transaction History

Benjamin F. Edwards & Company, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $702 - $2,973	-330 Reduced 62.26%	200 $0
Q1 2022 May 04, 2022	BUY	$6.28 - $15.59 $2,072 - $5,144	330 Added 165.0%	530 $4,000
Q4 2021 Feb 07, 2022	SELL	$14.7 - $28.67 $40,792 - $79,559	-2,775 Reduced 93.28%	200 $3,000
Q3 2021 Nov 02, 2021	BUY	$24.31 - $33.6 $9,724 - $13,440	400 Added 15.53%	2,975 $85,000
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $31,308 - $48,480	1,200 Added 87.27%	2,575 $87,000
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $23,142 - $39,851	700 Added 103.7%	1,375 $53,000
Q1 2020 May 07, 2020	BUY	$7.64 - $27.5 $3,629 - $13,062	475 Added 237.5%	675 $9,000
Q3 2019 Nov 05, 2019	SELL	$18.85 - $27.5 $11,310 - $16,500	-600 Reduced 75.0%	200 $4,000
Q2 2019 Aug 08, 2019	BUY	$17.37 - $26.27 $6,948 - $10,508	400 Added 100.0%	800 $19,000
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $4,260 - $10,300	400 New	400 $9,000
Q4 2017 Jan 17, 2018	SELL	$7.86 - $9.99 $6,067 - $7,712	-772 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$8.89 - $10.4 $6,863 - $8,028	772	772 $7,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.